R. Michael Snider

4.5k total citations · 1 hit paper
62 papers, 3.5k citations indexed

About

R. Michael Snider is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, R. Michael Snider has authored 62 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 31 papers in Cellular and Molecular Neuroscience and 7 papers in Genetics. Recurrent topics in R. Michael Snider's work include Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (24 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). R. Michael Snider is often cited by papers focused on Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (24 papers) and Pharmacological Receptor Mechanisms and Effects (8 papers). R. Michael Snider collaborates with scholars based in United States, Denmark and Japan. R. Michael Snider's co-authors include John Lowe, Kelly P. Longo, Manoj C. Desai, Elliott Richelson, Susan E. Drozda, Robin W. Spencer, Fredric J. Vinick, Heidi A. Woody, Jay W. Constantine and Wesley Lebel and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

R. Michael Snider

62 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Potent Nonpeptide Antagonist of the Substance P (NK ₁ ) Receptor

1991 727 citations R. Michael Snider, John Lowe et al. profile →

Peers

Countries citing papers authored by R. Michael Snider

Since Specialization

Citations

This map shows the geographic impact of R. Michael Snider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Michael Snider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Michael Snider more than expected).

Fields of papers citing papers by R. Michael Snider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Michael Snider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Michael Snider. The network helps show where R. Michael Snider may publish in the future.

Co-authorship network of co-authors of R. Michael Snider

This figure shows the co-authorship network connecting the top 25 collaborators of R. Michael Snider. A scholar is included among the top collaborators of R. Michael Snider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Michael Snider. R. Michael Snider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Homogeneous Time-Resolved Fluorescence Leukotriene B4 Assay for Determining the Activity of Leukotriene A4 Hydrolase 2007 ·SLAS DISCOVERY ·Amy Liang, Emmanuel Claret, (unknown), (unknown), David Vogel, David R. Light, Steven W. Jones, William J. Guilford, John F. Parkinson, R. Michael Snider	7
2	CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model 2001 ·Immunology Letters ·Richard Horuk, Sandra Shurey, Howard P. Ng, Karen May, John G. Bauman, Imadul Islam, Ameen Ghannam, Brad O. Buckman, Wei Guo, Wei Xu, Meina Liang, Mary P. Rosser, Laura Dunning, Joseph Hesselgesser, R. Michael Snider, Michael M. Morrissey, H. Daniel Perez, Colin Green	64
3	Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor 2000 ·European Journal of Pharmacology ·Meina Liang, Mary P. Rosser, Howard P. Ng, Karen May, John G. Bauman, Imadul Islam, Ameen Ghannam, Peter J. Kretschmer, Haifeng Pu, Laura Dunning, R. Michael Snider, Michael M. Morrissey, Joseph Hesselgesser, H. Daniel Perez, Richard Horuk	41
4	Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor 1998 ·Journal of Biological Chemistry ·Joseph Hesselgesser, Howard P. Ng, Meina Liang, Wei Zheng, Karen May, John G. Bauman, Sean Monahan, Imadul Islam, Wei Guo, Ameen Ghannam, Dennis D. Taub, Mary P. Rosser, R. Michael Snider, Michael M. Morrissey, H. Daniel Perez, Richard Horuk	106
5	Substance P increases neutrophil adhesion to bronchial epithelial cells. 1994 ·The Journal of Immunology ·(unknown), Richard Robbins, R. Michael Snider, John R. Spurzem, Geoffrey M. Thiele, Stephen I. Rennard, Israel Rubinstein	72
6	Aza-Tricyclic Substance P Antagonists 1994 ·Journal of Medicinal Chemistry ·John Lowe, Susan E. Drozda, Stafford McLean, Dianne K. Bryce, (unknown), R. Michael Snider, Kelly P. Longo, Atsushi Nagahisa, Megumi Tsuchiya	20
7	CP-99,994, a nonpeptide antagonist of the tachykinin NK1 receptor 1993 ·Regulatory Peptides ·Stafford McLean, R. Michael Snider, Manoj C. Desai, Terry Rosen, Dianne K. Bryce, Kelly P. Longo, Anne W. Schmidt, James Heym	29
8	Selective blockage of sensory response of the carotid body to hypoxia by NK-1 receptor antagonist CP-96,345 1993 ·Regulatory Peptides ·Nanduri R. Prabhakar, R. Michael Snider, John Lowe, Hailong Cao	2
9	A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline. 1993 ·Journal of Pharmacology and Experimental Therapeutics ·Giovanni Piedimonte, Claude Bertrand, Pierangelo Geppetti, R. Michael Snider, Manoj C. Desai, Jay A. Nadel	23
10	Discovery of CP-96,345 and its characterization in disease models involving substance P 1993 ·Regulatory Peptides ·John Lowe, Susan E. Drozda, R. Michael Snider, Kelly P. Longo, Stevin H. Zorn, (unknown), Jean Morrone, Stafford McLean, Dianne K. Bryce, Jon Bordner, Atsushi Nagahisa, Yoshihito Kanai, Osamu Suga, Megumi Tsuchiya	11
11	Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist 1993 ·Nature ·Ulrik Gether, Teit E. Johansen, R. Michael Snider, John Lowe, Shigetada Nakanishi, Thue W. Schwartz	187
12	Discovery of a potent substance P antagonist: recognition of the key molecular determinant 1992 ·Journal of Medicinal Chemistry ·Manoj C. Desai, (unknown), Peter F. Thadeio, Kelly P. Longo, R. Michael Snider	199
13	The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine as a novel, nonpeptide substance P antagonist 1992 ·Journal of Medicinal Chemistry ·John Lowe, Susan E. Drozda, R. Michael Snider, Kelly P. Longo, Stevin H. Zorn, Jean Morrone, (unknown), Stafford McLean, Dianne K. Bryce	89
14	A nicotinic receptor antagonist enhances the hypothermic response to a muscarinic agonist 1991 ·Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Steven C. Dilsaver, Mark J. Majchrzak, R. Michael Snider, R. Davidson	1
15	Differences in Glucose Transport Rates between Perfused andIn VitroIncubated Muscles 1990 ·Hormone and Metabolic Research ·Marialice Kern, Edward B. Tapscott, R. Michael Snider, G. Lynis Dohm	9
16	Repair of interrupted aortic arch in infancy 1988 ·Journal of Thoracic and Cardiovascular Surgery ·William Scott, Albert P. Rocchini, Edward L. Bove, Robert H. Beekman, Macdonald Dick, Gerald A. Serwer, R. Michael Snider, A Rosenthal, Douglas M. Behrendt	32
17	Effects of verapamil on left ventricular diastolic filling in children with hypertrophic cardiomyopathy 1988 ·The American Journal of Cardiology ·Elizabeth Shaffer, Albert P. Rocchini, Robert L. Spicer, Jack E. Juni, R. Michael Snider, Dennis C. Crowley, Amnon Rosenthal	10
18	Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology 1987 ·International Clinical Psychopharmacology ·(unknown), John F. Greden, R. Michael Snider	66
19	Stress induces supersensitivity of a cholinergic system in rats 1986 ·Biological Psychiatry ·Steven C. Dilsaver, R. Michael Snider, Norman E. Alessi	49
20	Thrombin Binding to Human Brain and Spinal Cord 1983 ·Mayo Clinic Proceedings ·Michael McKinney, R. Michael Snider, Elliott Richelson	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact